NewGenIvf Group (NIVF) Short Interest Ratio & Short Volume

Short interest is the volume of NewGenIvf Group shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 142,100 shares of NIVF short. 20.42% of NewGenIvf Group's shares are currently sold short. Learn More on NewGenIvf Group's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.42% of NewGenIvf Group's floating shares are currently sold short.

NewGenIvf Group saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 142,100 shares, a drop of 25.0% from the previous total of 189,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

NewGenIvf Group currently has issued a total of 5,271,000 shares. Some of NewGenIvf Group's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NewGenIvf Group currently has a public float of 695,800 shares.

20.42% of NewGenIvf Group's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to NewGenIvf Group: Ontrak, Inc. (1.78%), Agape ATP Co. (0.39%), Aclarion, Inc. (1.07%), ATI Physical Therapy, Inc. (5.31%), BioNexus Gene Lab Corp. (6.47%), Vsee Health, Inc. (0.65%), IMAC Holdings, Inc. (2.16%), Natera, Inc. (4.57%), Fresenius Medical Care AG (0.14%), Hims & Hers Health, Inc. (31.74%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

Short selling NIVF is an investing strategy that aims to generate trading profit from NewGenIvf Group as its price is falling. NIVF shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for NewGenIvf Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NIVF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NIVF, twice per month. The most recent reporting period available is March, 31 2025.